Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Minerva Cardioangiologica 2014 October;62(5) > Minerva Cardioangiologica 2014 October;62(5):421-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi

 

REVIEW   

Minerva Cardioangiologica 2014 October;62(5):421-6

Copyright © 2014 EDIZIONI MINERVA MEDICA

lingua: Inglese

Polymer-free amphilimus-eluting stents in patients with diabetes mellitus

Romaguera R., Gómez-Lara J., Jacobi F., Gomez-Hospital J. A., Cequier A.

Heart Diseases Institute, Hospital de Bellvitge‑IDIBELL, University of Barcelona, Barcelona, Spain


PDF


Despite several improvements in drug-eluting stents design, diabetes mellitus (DM) remains an Achilles’ heel for percutaneous coronary revascularization at the present time. The Cre8 stent is a third-generation drug-eluting stent devoid of polymer. The drug, which is formulated with an amphiphilic carrier, is eluted from laser-dug wells on the stent’s abluminal surface. The Cre8 stent hat has shown promising preliminary results in patients with DM. This review summarizes the mechanisms of DES failure in patients with DM and the potential role of the Cre8 stent in this high-risk population.

inizio pagina